{"organizations": [], "uuid": "2a2f78c8af8ef0a3368571527e54db4e506e2ee1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180413.html", "section_title": "Archive News &amp; Video for Friday, 13 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/ip-patent-vanda/patent-on-vanda-schizophrenia-drug-upheld-by-appeals-court-idUSL1N1RQ28F", "country": "US", "domain_rank": 408, "title": "Patent on Vanda schizophrenia drug upheld by appeals court", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.059, "site_type": "news", "published": "2018-04-14T07:13:00.000+03:00", "replies_count": 0, "uuid": "2a2f78c8af8ef0a3368571527e54db4e506e2ee1"}, "author": "Jan Wolfe", "url": "https://www.reuters.com/article/ip-patent-vanda/patent-on-vanda-schizophrenia-drug-upheld-by-appeals-court-idUSL1N1RQ28F", "ord_in_thread": 0, "title": "Patent on Vanda schizophrenia drug upheld by appeals court", "locations": [], "entities": {"persons": [{"name": "vanda", "sentiment": "negative"}, {"name": "west-ward", "sentiment": "none"}], "locations": [], "organizations": [{"name": "west-ward pharmaceuticals corp", "sentiment": "negative"}, {"name": "federal circuit", "sentiment": "none"}, {"name": "westlaw", "sentiment": "none"}, {"name": "u.s. court of appeals", "sentiment": "none"}, {"name": "vanda pharmaceutical inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "A federal appeals court on Friday ended a bid by West-Ward Pharmaceuticals Corp to invalidate a patent on Vanda Pharmaceutical Inc’s schizophrenia drug Fanapt and bring a lower-cost generic version to market.\nThe U.S. Court of Appeals for the Federal Circuit upheld a lower court ruling that a Vanda patent describing a method of using Fanapt to treat schizophrenia was valid and would be infringed by West-Ward’s proposed generic.\nTo read the full story on Westlaw Practitioner Insights, click here: bit.ly/2GZ3UDM\n ", "external_links": ["https://twitter.com/reuters", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://bit.ly/2GZ3UDM", "https://www.youtube.com/user/ReutersVideo", "https://instagram.com/reuters/"], "published": "2018-04-14T07:13:00.000+03:00", "crawled": "2018-04-14T13:23:23.000+03:00", "highlightTitle": ""}